Prostate Cancer Update (2024): Expert Guidance for Urologists

CME Available: https://auau.auanet.org/node/41868

Acknowledgements

Support provided by independent educational grants from:

Astellas

Lantheus Medical Imaging

Novartis Pharmaceuticals Corporation

Pfizer, Inc.

Learning Objectives

At the conclusion of this activity, the learner will:

1. Align their practice with current AUA Guidelines (and recent amendments) pertaining to Screening, Diagnosis, and Management of Prostate Cancer.

2. Determine appropriate use of biomarker testing as it relates to diagnosis and therapy.

3. Analyze the role of imaging and types of imaging that aid in staging patients with prostate cancer.

4. Implement appropriate treatment paradigms for metastatic prostate cancer including treatment intensification.

5. Discuss the role of genetic and molecular profiling in the personalization of prostate cancer treatment plans.